Skip to main content
logo
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.8173
-0.0227 (-2.70%)
At close: Mar 19, 2026, 4:00 PM EDT
0.8190
+0.0017 (0.21%)
After-hours: Mar 19, 2026, 6:25 PM EDT

Heron Therapeutics Revenue

In the year 2025, Heron Therapeutics had annual revenue of $154.90M with 7.36% growth. Heron Therapeutics had revenue of $40.59M in the quarter ending December 31, 2025, a decrease of -0.47%.

Revenue (ttm)
$154.90M
Revenue Growth
+7.36%
P/S Ratio
0.99
Revenue / Employee
$1,210,188
Employees
128
Market Cap
154.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025154.90M10.62M7.36%
Dec 31, 2024144.29M17.24M13.57%
Dec 31, 2023127.04M19.37M17.99%
Dec 31, 2022107.67M21.33M24.70%
Dec 31, 202186.35M-2.29M-2.59%
Dec 31, 202088.64M-57.33M-39.28%
Dec 31, 2019145.97M68.49M88.41%
Dec 31, 201877.47M46.71M151.81%
Dec 31, 201730.77M29.49M2,305.55%
Dec 31, 20161.28M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011646.00K-655.00K-50.35%
Dec 31, 20101.30M40.00K3.17%
Dec 31, 20091.26M892.00K241.73%
Dec 31, 2008369.00K-43.00K-10.44%
Dec 31, 2007412.00K--
Dec 31, 2006---
Dec 31, 20055.39M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

HRTX News

More News